Observational study on rare gynecological cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational, multicenter registry focused on understanding the prognosis, clinical and pathological features, and management of rare gynecological tumors. The study aims to gather comprehensive data to improve the standard of care for patients with these rare malignancies. Participants will be monitored over time to assess treatment outcomes and disease progression.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* rare gynecological malignancies
* written informed consent
* patient fit for follow-up

Exclusion criteria

-written informed consent not provided

Where it's running

• Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele
  Milan, Italy Recruiting
• IRCCS Fondazione G Pascale
  Naples, Italy Recruiting

Study contacts

• Principal investigator: Francesco Perrone, MD — IRCCS Fondazione G Pascale, Naples
• Study coordinator: Francesco Perrone, MD
• Email: f.perrone@istitutotumori.na.it
• Phone: 0039 081 1777 0276

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• NMTCuff vs standard TOF monitoring during gynecologic oncology surgery

  This study tests whether NMTCuff monitoring can better detect neuromuscular recovery than standard TOF monitoring in women undergoing laparoscopic gynecologic cancer surgery.

  Recruiting Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Ankara · NCT07925463

• Radiotherapy for gynecologic cancer with up to 10 metastatic sites

  This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość · NCT07883798

• Personalized supervised exercise program for adults with breast or gynecologic cancer

  A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.

  Recruiting University of Iowa · Iowa City, Iowa · NCT07765927

• Cesium-131 brachytherapy to preserve organs in recurrent cervical or endometrial cancer

  This study tests whether implanting small cesium-131 seeds can provide targeted radiation to vaginal recurrences of cervical or endometrial cancer in patients who previously had pelvic radiation, with the goal of preserving organs.

  Recruiting University of Kentucky · Lexington, Kentucky · NCT07631572

• National registry of endometrial cancer cases in Italy

  This project will collect clinical and molecular information from adults treated for endometrial cancer at participating Italian oncology centers to see if a national database can improve understanding of outcomes and care.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07558889

• High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)

  This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07524114

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.